Transforming Sanofi-Aventis
|
|
ICMR HOME | Case Studies Collection
Case Details:
Case Code : BSTR358
Case Length : 18 Pages
Period : 2008-2009
Pub Date : 2010
Teaching Note :Not Available
Organization : Sanofi-Aventis
Industry : Healthcare / Pharmaceuticals
Countries : France; Global
To download Transforming Sanofi-Aventis case study
(Case Code: BSTR358) click on the button below, and select the case from the list of available cases:
Price:
For delivery in electronic format: Rs. 300;
For delivery through courier (within India): Rs. 300 + Rs. 25 for Shipping & Handling Charges
» Business Strategy Case Studies
» Case Studies Collection
» Business Strategy Short Case Studies
» View Detailed Pricing Info
» How To Order This Case
» Business Case Studies
» Area Specific Case Studies
» Industry Wise Case Studies
» Company Wise Case Studies
Please note:
This case study was compiled from published sources, and is intended to be used as a basis for class discussion. It is not intended to illustrate either effective or ineffective handling of a management situation. Nor is it a primary information source.
|
|
<< Previous
Introduction Contd...
|
It reported sales of €27,438 million for Q2 2009 as compared to €6,689 million for the corresponding period of 2008.3 Its stocks had also grown faster than that of its peer group
- a complete reversal of fortunes for a company whose stocks had been considered the worst performing of its peer group barely a year earlier (Refer to Exhibit I for Sanofi-Aventis' consolidated income statement for the first half of 2009; and, Exhibit II for its five-year stock chart).
However, analysts also felt that, going forward, Viehbacher was likely to come up against many tough challenges. The Paris-based Sanofi-Aventis was the world's third largest pharmaceutical company as of 2009.
|
|
However, experts felt that it had a costly and unproductive research and development (R&D) pipeline, with few new products in sight to offset the impact of patent expiries of its top-selling drugs between 2009 and 2013...
Excerpts >>
|
